Evidence mapPaperPMID 38770409Full record

ArticleHealth affairs scholar2023

US practice adoption of patient-engagement strategies and spending for adults with diabetes and cardiovascular disease.

Hector P Rodriguez, Karl Rubio, Chris Miller-Rosales, Andrew J Wood

Abstract read
In one paragraph

Article in Health affairs scholar, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hector P RodriguezDivision of Health Policy and Management, School of Public Health, University of California, Berkeley, 2121 Berkeley Way West #5427, Berkeley, CA 94704, United States.ORCID https://orcid.org/0000-0002-6564-2229
Karl RubioDivision of Health Policy and Management, School of Public Health, University of California, Berkeley, 2121 Berkeley Way West #5427, Berkeley, CA 94704, United States.
Chris Miller-RosalesDivision of Health Policy and Management, School of Public Health, University of California, Berkeley, 2121 Berkeley Way West #5427, Berkeley, CA 94704, United States.ORCID https://orcid.org/0000-0003-4430-5968
Andrew J WoodDartmouth Institute for Health Policy and Clinical Practice, Dartmouth College, 1 Medical Center Dr, Lebanon, NH 03756, United States.ORCID https://orcid.org/0000-0003-3948-4869

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patient-engagement strategies are being encouraged by payers and governments, but with limited evidence about whether practice adoption of these strategies impacts utilization and spending. We examine the association of physician practice adoption of patient-engagement strategies (low vs moderate vs high) with potentially preventable utilization and total spending for patients with type 2 diabetes and/or cardiovascular disease using US physician practice survey (n = 2086) and Medicare fee-for-service (n = 736 269) data. In adjusted analyses, there were no differences in potentially preventable utilization associated with practice adoption of patient-engagement strategies. Compared with patients attributed to practices with moderate adoption, patients attributed to practices with high adoption had higher total spending ($26 364 vs $25 991;

Indexed as

diabetesorganization of carepatient engagementshared decision-makingspending

Identifiers

PMID38770409
PMCPMC11103728

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.